Detalles de la búsqueda
1.
Targeted therapy in colorectal cancer.
Clin Colorectal Cancer
; 6(5): 357-61, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17311700
2.
Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion.
J Clin Oncol
; 22(9): 1553-63, 2004 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15117978
3.
Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93.
J Clin Oncol
; 21(11): 2110-4, 2003 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12775736
4.
Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.
J Clin Oncol
; 21(7): 1313-9, 2003 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12663720
5.
Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study.
J Clin Oncol
; 21(15): 2843-8, 2003 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12807937
6.
Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group.
J Clin Oncol
; 22(1): 120-6, 2004 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14701774
7.
Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer.
J Clin Oncol
; 21(8): 1498-504, 2003 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12697873
8.
Recommended guidelines for the treatment of cancer treatment-induced diarrhea.
J Clin Oncol
; 22(14): 2918-26, 2004 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15254061
9.
Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.
Clin Cancer Res
; 9(2): 693-702, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12576437
10.
Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants.
Clin Cancer Res
; 9(1): 33-43, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12538449
11.
Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous cell cancer of the uterine cervix.
Int J Radiat Oncol Biol Phys
; 52(3): 637-42, 2002 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11849784
12.
SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.
Biochem Pharmacol
; 64(7): 1091-100, 2002 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12234612
13.
Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
Clin Colorectal Cancer
; 2(3): 173-9, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12482334
14.
Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
Cancer Chemother Pharmacol
; 53(4): 337-40, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-14704829
15.
Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma.
Arch Otolaryngol Head Neck Surg
; 130(7): 831-6, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15262759
16.
Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies.
Am J Clin Oncol
; 25(5): 528-34, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12393999
17.
Report of a phase I evaluation of dose and schedule of interleukin-1 alpha and cyclophosphamide in patients with advanced tumors: An Eastern Cooperative Oncology Group study (PX990) and review of IL-1-based studies of hematopoietic reconstitution.
J Interferon Cytokine Res
; 34(5): 376-84, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24433038
18.
The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinoma.
Clin Cancer Res
; 11(7): 2781-2; author reply 2782, 2005 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15814661
19.
A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.
Clin Colorectal Cancer
; 10(2): 85-96, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21859559
20.
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.
Cancer Chemother Pharmacol
; 64(4): 803-10, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19221754